NASDAQ: SNSE
Sensei Biotherapeutics Inc Stock Ownership - Who owns Sensei Biotherapeutics?

Insider buying vs selling

Have Sensei Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John CelebiPRESIDENT AND CEO2025-02-195,558$0.48
$2.65kSell
Der Horst Edward VanCHIEF SCIENTIFIC OFFICER2025-02-192,276$0.48
$1.08kSell

1 of 1

SNSE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SNSE insiders and whales buy or sell their stock.

SNSE Shareholders

What type of owners hold Sensei Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James Peyer35.07%8,841,457$3.59MInsider
Hs Investments I LP17.56%4,425,998$1.80MInsider
Cambrian Biopharma Inc14.49%3,653,120$1.48MInsider
Thomas G. Ricks2.72%685,632$278.37kInsider
Ikarian Capital LLC2.58%649,963$263.88kInstitution
Vanguard Group Inc2.36%594,454$241.35kInstitution
Catalio Capital Management LP1.17%294,374$119.52kInstitution
Boothbay Fund Management LLC0.69%172,798$70.16kInstitution
Renaissance Technologies LLC0.62%156,800$63.66kInstitution
Geode Capital Management LLC0.59%148,887$60.45kInstitution

1 of 3

SNSE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNSE9.31%71.61%Net SellingNet Selling
NXTC53.37%46.63%
HOTH1.85%57.63%Net Buying
RLYB43.21%56.79%
TRAW4.36%95.64%Net BuyingNet Buying

Sensei Biotherapeutics Stock Ownership FAQ

Who owns Sensei Biotherapeutics?

Sensei Biotherapeutics (NASDAQ: SNSE) is owned by 9.31% institutional shareholders, 71.61% Sensei Biotherapeutics insiders, and 19.07% retail investors. James Peyer is the largest individual Sensei Biotherapeutics shareholder, owning 8.84M shares representing 35.07% of the company. James Peyer's Sensei Biotherapeutics shares are currently valued at $3.59M.

If you're new to stock investing, here's how to buy Sensei Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.